Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of the genomic regions controlled by SMAD4 in alveolar macrophages (SMAD4 HT-ChIPmentation)

ABSTRACT: The goal of this study was to define the cistrome of SMAD4 by HT-ChIPmentation followed by sequencing in alveolar macrophages of wild-type mice, in order to identify genomic regions directly controlled by this transcription factor.

ORGANISM(S): Mus musculus

PROVIDER: GSE255365 | GEO | 2026/05/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Analysis of the genomic regions controlled by RXRα in alveolar macrophages (RXR HT-ChIPmentation)

Project description:The goal of this study was to define the cistrome of RXR by HT-ChIPmentation followed by sequencing in alveolar macrophages of wild-type and RXRαβ-deficient mice, in order to identify genomic regions directly controlled by these transcription factors. Due to technical antibody limitations, the ChIPmentation was performed using only the antibody against RXRα

2026-05-13 | GSE243164 | GEO

Analysis of the genomic regions controlled by RBPJ in alveolar macrophages (RBPJ HT-ChIPmentation)

Project description:The goal of this study was to define the cistrome of RBPJ by HT-ChIPmentation followed by sequencing in alveolar macrophages of wild-type mice, in order to identify genomic regions directly controlled by this transcription factor.

2026-05-13 | GSE314336 | GEO

Analysis of the genomic regions controlled by PPARγ in alveolar macrophages (PPARγ HT-ChIPmentation)

Project description:The goal of this study was to define the cistrome of PPARγ by HT-ChIPmentation followed by sequencing in alveolar macrophages of wild-type mice, in order to identify genomic regions directly controlled by this transcription factor.

2026-05-13 | GSE314337 | GEO

Analysis of the genomic regions controlled by SMAD4 in alveolar macrophages (SMAD4 HT-ChIPmentation)

Project description:Analysis of the genomic regions controlled by SMAD4 in alveolar macrophages (SMAD4 HT-ChIPmentation)

| PRJNA1074748 | ENA

Transcriptionally active genomic regions defined by H3K27ac mark (H3K27ac HT-ChIPmentation)

Project description:The goal of this study was to define the acetylation mark H3K27ac profile by HT-ChIPmentation followed by sequencing in alveolar macrophages of wild-type mice, allowing us to identify the transcriptionally-active genomic regions.

2026-05-13 | GSE243163 | GEO

Analysis of the genomic regions controlled by RBPJ in alveolar macrophages (RBPJ HT-ChIPmentation)

Project description:Analysis of the genomic regions controlled by RBPJ in alveolar macrophages (RBPJ HT-ChIPmentation)

| PRJNA1390735 | ENA

Analysis of the genomic regions controlled by PPARγ in alveolar macrophages (PPARγ HT-ChIPmentation)

Project description:Analysis of the genomic regions controlled by PPARγ in alveolar macrophages (PPARγ HT-ChIPmentation)

| PRJNA1390737 | ENA

Analysis of the genomic regions controlled by RXRα in alveolar macrophages (RXR HT-ChIPmentation)

Project description:Analysis of the genomic regions controlled by RXRα in alveolar macrophages (RXR HT-ChIPmentation)

| PRJNA1016459 | ENA

Transcriptionally active genomic regions defined by H3K27ac mark (H3K27ac HT-ChIPmentation)

Project description:Transcriptionally active genomic regions defined by H3K27ac mark (H3K27ac HT-ChIPmentation)

| PRJNA1016456 | ENA

SMAD4-NFATc1 protein-protein interaction informed therapeutic vulnerability in SMAD4-deficient pancreatic cancer

Project description:Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by a median survival rate of approximately six months. While genetic profiling has uncovered common mutations in PDAC, developing targeted therapeutic strategies remains challenging. SMAD4 is frequently mutated or deleted in 30-55% of PDAC patients and correlates with poor survival rates. Such mutations frequently result in loss-of-function, thereby disrupting normal cell cycle regulation and contributing to tumorigenesis. Therefore, translating SMAD4 genotype into actionable targets are highly desired for therapeutic innovation in PDAC. In this study, we performed a SMAD4-focused oncogenic protein-protein interaction (oncoPPI) network mapping and revealed a direct physical interaction between SMAD4 and NFATc1. We found that SMAD4 interacts with NFATc1 in a TGF-independent and NFATc1 phosphorylation-dependent manner. Further, SMAD4 sequesters NFATc1 in cytoplasm and inhibits NFATc1 transcriptional activity. In PDAC cells, SMAD4-loss releases its inhibitory activity on NFATc1, activates NFATc1 transcriptional activity which drives STAT3 mRNA and protein upregulation. Pharmacological profiling identified multiple STAT3 inhibitors selectively inhibit the growth of SMAD4-loss PDAC cells. These results suggested a rewired SMAD4-NFATc1-STAT3 axis and targeting STAT3 as a potential therapeutic strategy in SMAD4-loss PDAC.

2026-02-02 | PXD067749 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data